FDA official logo
GSRS logoPFDA official logo

REVUMENIB CITRATE

UNII:YL4RYN734D
Type:INGREDIENT SUBSTANCE
Formula:C32H47FN6O4S.C6H8O7.H2O
Preferred Substance Name:REVUMENIB CITRATE
InChIKey:
GSRS Full Record:

  • 2761046-45-9
  • 2-{[4-(7-{[trans-4-(ethanesulfonamido)cyclohexyl]methyl}-2,7-diazaspiro[3.5]nonan-2-yl)pyrimidin-5-yl]oxy}-N-ethyl-5-fluoro-N-(propan-2-yl)benzamide—2-hydroxypropane-1,2,3-tricarboxylic acid monohydrate
  • Benzamide, N-ethyl-2-[[4-[7-[[trans-4-[(ethylsulfonyl)amino]cyclohexyl]methyl]-2,7-diazaspiro[3.5]non-2-yl]-5-pyrimidinyl]oxy]-5-fluoro-N-(1-methylethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate, hydrate (1:1:1)
  • REVUFORJ
  • REVUMENIB CITRATE [USAN]
  • REVUMENIB MONOCITRATE MONOHYDRATE
  • Revumenib Citrate
  • Revumenib citrate [WHO-DD]
  • Revumenib citrate hydrate [MI]



UNII - YL4RYN734D | UNII Search Service